Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A7

    
• • ·Information for Readers

    Page :A8

    

• Editorials

  • ·A call to standardize symptom presentation in acute coronary syndromes

    Page :801-806

    John G. Canto, Robert J. Goldberg, George Sopko

    Plan Plan  
  • ·Invited editorial commentary for American Heart Journal mechanisms of exercise training in heart failure with preserved ejection fraction: Central disappointment and peripheral promise

    Page :807-809

    Dalane W. Kitzman, Mark J. Haykowsky

    

• Trial Design

  • ·Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

    Page :810

    Fausto Feres, Ricardo A. Costa, Deepak L. Bhatt, Martin B. Leon, Roberto V. Botelho, Spencer B. King, J. Eduardo T. de Paula, José A. Mangione, Décio Salvadori, Marcos O. Gusmão, Hélio Castello, Eduardo Nicolela, Marco A. Perin, Fernando S. Devito, J. Antônio Marin-Neto, Alexandre Abizaid

    Résumé Résumé Plan Plan  
  • ·Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

    Page :817

    Philippe Gabriel Steg, Shamir R. Mehta, Charles V. Pollack, Christoph Bode, Christophe Gaudin, Karen Fanouillere, Angele Moryusef, Stephen D. Wiviott, Marc S. Sabatine

    Résumé Résumé Plan Plan  
  • ·Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies

    Page :825-834

    Sean P. Collins, Christopher J. Lindsell, Cathy A. Jenkins, Frank E. Harrell, Gregory J. Fermann, Karen F. Miller, Sue N. Roll, Matthew I. Sperling, David J. Maron, Allen J. Naftilan, John A. McPherson, Neal L. Weintraub, Douglas B. Sawyer, Alan B. Storrow

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·A qualitative systematic review of influences on attendance at cardiac rehabilitation programs after referral

    Page :835

    Alexander M. Clark, Kathryn M. King-Shier, David R. Thompson, Melisa A. Spaling, Amanda S. Duncan, James A. Stone, Susan B. Jaglal, Jan E. Angus

    Résumé Résumé Plan Plan  

• Cardiac Safety Research Consortium

  • ·Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction

    Page :846-855

    Jennifer B. Christian, John K. Finkle, Bonnie Ky, Pamela S. Douglas, David E. Gutstein, Paul D. Hockings, Pierre Lainee, Daniel J. Lenihan, Jay W. Mason, Philip T. Sager, Thomas G. Todaro, Karen A. Hicks, Robert C. Kane, Hon-Sum Ko, JoAnn Lindenfeld, Eric L. Michelson, James Milligan, Jiefen Y. Munley, Joel S. Raichlen, Amir Shahlaee, Colette Strnadova, Brenda Ye, J. Rick Turner

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·Presenting symptoms of myocardial infarction predict short- and long-term mortality: The MONICA/KORA Myocardial Infarction Registry

    Page :856-861

    Inge Kirchberger, Margit Heier, Bernhard Kuch, Wolfgang von Scheidt, Christa Meisinger

    Résumé Résumé Plan Plan  
  • ·Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure

    Page :862-868

    Ravi V. Shah, Steven McNulty, Christopher M. O'Connor, G. Michael Felker, Eugene Braunwald, Michael M. Givertz

    Résumé Résumé Plan Plan  
  • ·Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction

    Page :869-877

    Naoki Fujimoto, Anand Prasad, Jeffrey L. Hastings, Paul S. Bhella, Shigeki Shibata, Dean Palmer, Benjamin D. Levine

    Résumé Résumé Plan Plan  
  • ·The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

    Page :878-883

    Lars Gullestad, Thor Ueland, John Kjekshus, Ståle H. Nymo, Johannes Hulthe, Pieter Muntendam, John J.V. McMurray, John Wikstrand, Pål Aukrust

    Résumé Résumé Plan Plan  
  • ·Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

    Page :884

    Robert J. Mentz, Matthew J. Chung, Mihai Gheorghiade, Peter S. Pang, Mary J. Kwasny, Andrew P. Ambrosy, Muthiah Vaduganathan, Christopher M. O'Connor, Karl Swedberg, Faiez Zannad, Marvin A. Konstam, Aldo P. Maggioni

    Résumé Résumé Plan Plan  
  • ·Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study

    Page :893-901

    Martin Stout, Garry A. Tew, Helen Doll, Irena Zwierska, Nicola Woodroofe, Kevin S. Channer, John M. Saxton

    Résumé Résumé Plan Plan  
  • ·Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

    Page :902

    Hector Tamez, Carmine Zoccali, David Packham, Julia Wenger, Ishir Bhan, Evan Appelbaum, Yili Pritchett, Yuchiao Chang, Rajiv Agarwal, Christoph Wanner, Donald Lloyd-Jones, Jorge Cannata, B. Taylor Thompson, Dennis Andress, Wuyan Zhang, Bhupinder Singh, Daniel Zehnder, Ajay Pachika, Warren J. Manning, Amil Shah, Scott D. Solomon, Ravi Thadhani

    Résumé Résumé Plan Plan  
  • ·Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score–matched case-control study

    Page :910-917

    Azeem Latib, Francesco Maisano, Letizia Bertoldi, Andrea Giacomini, Joanne Shannon, Micaela Cioni, Alfonso Ielasi, Filippo Figini, Kensuke Tagaki, Annalisa Franco, Remo Daniel Covello, Antonio Grimaldi, Pietro Spagnolo, Gill Louise Buchannan, Mauro Carlino, Alaide Chieffo, Matteo Montorfano, Ottavio Alfieri, Antonio Colombo

    Résumé Résumé Plan Plan  
  • ·Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery

    Page :918-924

    Prashant D. Bhave, L. Elizabeth Goldman, Eric Vittinghoff, Judith Maselli, Andrew Auerbach

    Résumé Résumé Plan Plan
  • ·Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation

    Page :925

    Paul E. Drawz, Sarah Baraniuk, Barry R. Davis, Clinton D. Brown, Pedro J. Colon, Aloysius B. Cujyet, Richard A. Dart, James F. Graumlich, Mario A. Henriquez, Jamaluddin Moloo, Mohammed G. Sakalayen, Debra L. Simmons, Carol Stanford, Mary Ellen Sweeney, Nathan D. Wong, Mahboob Rahman

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

    Page :e19

    Gen-Min Lin, Yi-Hwei Li, Lamin E.S. Jaiteh, Chih-Lu Han

    
  • ·Blocking the terminal complement complex: Mismatch and misconception

    Page :e21

    Pierre Theroux, Catherine Martel, Arnaud Bonnefoy

    
  • ·Letter to the Editor concerning article “Design of the Trial to Assess Chelation Therapy (TACT)”

    Page :e23

    Edzard Ernst

    
  • ·Reply to letter to the editor by Edzard Ernst

    Page :e25

    Gervasio A. Lamas